Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection.
Valdivia
L A
LA
Pittsburgh Transplant Institute, University of Pittsburgh Health Science Center, Pennsylvania 15213.
Fung
J J
JJ
Demetris
A J
AJ
Celli
S
S
Pan
F
F
Tsugita
M
M
Starzl
T E
TE
D000818:Animals; D003165:Complement System Proteins / Q000276:immunology*; D006224:Cricetinae; D003520:Cyclophosphamide / Q000627:therapeutic use; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000276:immunology*; D007106:Immune Sera / Q000008:administration & dosage / Q000276:immunology; D007165:Immunosuppression Therapy / Q000379:methods; D016031:Liver Transplantation / Q000276:immunology*; D051381:Rats; D011917:Rats, Inbred Lew; D013045:Species Specificity; D016559:Tacrolimus / Q000627:therapeutic use; D014183:Transplantation, Heterologous / Q000276:immunology*
D007106:Immune Sera; D003520:Cyclophosphamide; D003165:Complement System Proteins; D016559:Tacrolimus